United States · FDA National Drug Code directory
etodolac
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83980-029_4064e892-4c7a-46a7-9114-3e2bf466e597
- Product NDC
- 83980-029
- Form
- TABLET
- Composition / generic term
- etodolac
- Labeler
- Ipca Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260213
- Source listing expiry
- 20271231
Source-listed ingredients
- ETODOLAC — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (83980-029-01) · 83980-029-01
- 1000 TABLET in 1 BOTTLE (83980-029-10) · 83980-029-10
- 30 TABLET in 1 BOTTLE (83980-029-13) · 83980-029-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →